As a therapeutic end point for pulsed-dye laser treatment of a port wine stain, immediate post-irradiation vessel disappearance was comparable in efficacy/safety to purpura and may be more convenient.
A patient presents to the emergency department complaining of a severe rash affecting his face, torso, and armpits.
Reactivation of the dormant herpes zoster virus (HZV), once believed to occur only in advanced adulthood, has been increasingly observed in children within just a few years of original exposure to the varicella zoster virus (VZV), according to study data published in Dermatologic Therapy. Results of this study indicated that, contrary to common belief, immunosuppression…
According to study data published in the Journal of the American Academy of Dermatology, environmental exposure to ultraviolet (UV) light may reduce the risk for mycosis fungoides. Investigators used the Surveillance, Epidemiology, and End Results-18 (SEER-18) database to identify adult patients (age ≥20 years) with mycosis fungoides and/or Sézary syndrome. Patients were followed from January…
In-office laser devices and intense pulsed light treatments are similar for unwanted hair removal in patients with pigmented skin types; however, investigators note a trend toward greater hair reduction when using lasers.
Researchers compared 1-day intravenous dexamethasone pulses with 3-day pulses in a small cohort of children and adolescents with severe AA.
More patients treated with ligelizumab achieved complete control of urticarial symptoms than patients who received omalizumab, a study finds.
SB206 12% represents a well-tolerated topical treatment for molluscum contagiosum that can be applied at home by patients or caregivers, solving an unmet medical need.
While ivermectin plus albendazole was not superior in the treatment of onchocerciasis compared with ivermectin alone, semiannual treatment with or without albendazole was superior to annual treatment for suppressing microfilaria in the skin.
Investigators evaluated the treatment of chronic pruritus with tofacitinib in patients with concomitant rheumatoid arthritis.